Please don't forget ELTP guys. All you need to do is check the stickies and the pipeline at elitepharma.com to realize was a golden company this is. It is still hugely undervalued.
I have been in it for three years. It has an almost manic following of devoutists and bashers alike. It will pay off in dollars easily as a long term hold (1-3 years), but will most likely be bought out by Big Pharma soon. Their abuse resistant tech combined with opioids is patented, stabile and effective.
Nasrat Hakim (ex VP for Activas) has been kicking butt since last August when he joined Elite. He had coffee mugs made for his staff, "2014 the Year of Elite".
The stock gets wash traded and manipulated, but your money is safe and it WILL pay off. Good long investment and a bargain @ .39.
It is well to remember that the entire universe, with one trifling exception, is composed of others. — John Andrew Holmes
